Biocept | BIOC - Interest Expense On Debt

Biocept reported $52K in Interest Expense on Debt for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Interest Expense On Debt Change
Abbott ABT:US USD 66M 75M
Becton, Dickinson and BDX:US USD 102M 2M
Biocept BIOC:US USD 52K 103K
Cytori Therapeutics CYTX:US USD 159K 14K
Roche Holding ROG:VX 348M 92M
Thermo Fisher Scientific TMO:US USD 269M 96M